000 | 01960 a2200601 4500 | ||
---|---|---|---|
005 | 20250516033256.0 | ||
264 | 0 | _c20120120 | |
008 | 201201s 0 0 eng d | ||
022 | _a1499-2752 | ||
024 | 7 |
_a10.3899/jrheum.100221 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKhan, Aliya A | |
245 | 0 | 0 |
_aBisphosphonate-associated osteonecrosis of the jaw in Ontario: a survey of oral and maxillofacial surgeons. _h[electronic resource] |
260 |
_bThe Journal of rheumatology _cJul 2011 |
||
300 |
_a1396-402 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdministration, Oral |
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aBisphosphonate-Associated Osteonecrosis of the Jaw _xepidemiology |
650 | 0 | 4 |
_aBone Diseases, Metabolic _xdrug therapy |
650 | 0 | 4 | _aChild |
650 | 0 | 4 |
_aDiphosphonates _xadministration & dosage |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHealth Surveys |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIncidence |
650 | 0 | 4 | _aInjections, Intravenous |
650 | 0 | 4 | _aLongitudinal Studies |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
650 | 0 | 4 |
_aOntario _xepidemiology |
650 | 0 | 4 |
_aOsteoporosis _xdrug therapy |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aSurgery, Oral |
650 | 0 | 4 | _aSurveys and Questionnaires |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aRios, Lorena P | |
700 | 1 | _aSándor, George K B | |
700 | 1 | _aKhan, Nazir | |
700 | 1 | _aPeters, Edmund | |
700 | 1 | _aRahman, Mohammed O | |
700 | 1 | _aClokie, Cameron M L | |
700 | 1 | _aDore, Edward | |
700 | 1 | _aDubois, Sacha | |
773 | 0 |
_tThe Journal of rheumatology _gvol. 38 _gno. 7 _gp. 1396-402 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.3899/jrheum.100221 _zAvailable from publisher's website |
999 |
_c20764388 _d20764388 |